BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8985034)

  • 1. Selective tumor irradiation by infusional brachytherapy in nonresectable pancreatic cancer: a phase I study.
    Order SE; Siegel JA; Principato R; Zeiger LE; Johnson E; Lang P; Lustig R; Wallner PE
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1117-26. PubMed ID: 8985034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete remission of nonresectable pancreatic cancer after infusional colloidal phosphorus-32 brachytherapy, external beam radiation therapy, and 5-fluorouracil: a preliminary report.
    DeNittis AS; Stambaugh MD; Lang P; Wallner PE; Lustig RA; Dillman RO; Order SE
    Am J Clin Oncol; 1999 Aug; 22(4):355-60. PubMed ID: 10440189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of various therapeutic solutions including colloidal chromic 32P via an intratumoral injection on the tumor physiological parameters of AsPC-1 human pancreatic tumor xenografts in nude mice.
    Lee I; Lee YH
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3139s-3142s. PubMed ID: 10541354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary experience of infusional brachytherapy using colloidal 32P.
    Order SE; Siegel JA; Principato R; Zeiger LS; Johnson E; Lang P; Lustig R; Kroprowski C; Wallner PE
    Ann Acad Med Singap; 1996 May; 25(3):347-51. PubMed ID: 8876899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor type and vascularity: important variables in infusional brachytherapy with colloidal 32P.
    Nguyen H; Ghanem G; Morandini R; Verbist A; Larsimont D; Fallais C; Frühling J; Van Houtte P
    Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):481-7. PubMed ID: 9308954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres.
    Lau WY; Ho S; Leung TW; Chan M; Ho R; Johnson PJ; Li AK
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):583-92. PubMed ID: 9486608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Objective responses after fractionated infusional brachytherapy of unresectable pancreatic adenocarcinomas.
    Westlin JE; Andersson-Forsman C; Garske U; Linné T; Aas M; Glimelius B; Lindgren PG; Order SE; Nilsson S
    Cancer; 1997 Dec; 80(12 Suppl):2743-8. PubMed ID: 9406733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palladium-103: a new radioactive source in the treatment of unresectable carcinoma of the pancreas: a phase I-II study.
    Nori D; Merimsky O; Osian AD; Heffernan M; Cortes E; Turner JW
    J Surg Oncol; 1996 Apr; 61(4):300-5. PubMed ID: 8628003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic ultrasound-guided interstitial brachytherapy of unresectable pancreatic cancer: results of a pilot trial.
    Sun S; Xu H; Xin J; Liu J; Guo Q; Li S
    Endoscopy; 2006 Apr; 38(4):399-403. PubMed ID: 16680642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of a T1 cancer of the pancreatic head with high dose rate brachytherapy and external radiotherapy.
    Takácsi-Nagy Z; Varga J; Poller I; Fodor J; Polgár C; Petrányi A; Major T; Németh G
    Hepatogastroenterology; 2002; 49(45):844-6. PubMed ID: 12064004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility study of the treatment of primary unresectable carcinoma of the pancreas with 103Pd brachytherapy.
    Raben A; Mychalczak B; Brennan MF; Minsky B; Anderson L; Casper ES; Harrison LB
    Int J Radiat Oncol Biol Phys; 1996 May; 35(2):351-6. PubMed ID: 8635943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi-institutional trial (Radiation Therapy Oncology Group Protocol 8801).
    Komaki R; Wadler S; Peters T; Byhardt RW; Order S; Gallagher MJ; Herskovic A; Pederson J
    Cancer; 1992 Jun; 69(11):2807-12. PubMed ID: 1571912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of CT-guided high-dose-rate interstitial brachytherapy in primary and secondary malignancies of the pancreas.
    Omari J; Heinze C; Wilck A; Hass P; Seidensticker M; Seidensticker R; Mohnike K; Ricke J; Pech M; Powerski M
    Eur J Radiol; 2019 Mar; 112():22-27. PubMed ID: 30777214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer.
    Wanebo HJ; Glicksman AS; Vezeridis MP; Clark J; Tibbetts L; Koness RJ; Levy A
    Arch Surg; 2000 Jan; 135(1):81-7; discussion 88. PubMed ID: 10636353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced tumor targeting by an intratumoral injection of colloidal chromic 32P in two human tumors (AsPC-1 pancreas and Ls174T colon) in nude mice.
    Lee I
    J Surg Oncol; 1999 Mar; 70(3):161-6. PubMed ID: 10102345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial hyperthermia and high dose rate brachytherapy in the treatment of anal cancer: a phase I/II study.
    Kapp KS; Kapp DS; Stuecklschweiger G; Berger A; Geyer E
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):189-99. PubMed ID: 8270441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report.
    Gaspar LE; Qian C; Kocha WI; Coia LR; Herskovic A; Graham M
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):593-9. PubMed ID: 9112458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-fluorouracil-based chemoradiation in unresectable pancreatic carcinoma: Phase I-II dose-escalation study.
    Morganti AG; Valentini V; Macchia G; Mattiucci GC; Costamagna G; Deodato F; Smaniotto D; Luzi S; Balducci M; Barbi S; Perri V; Trodella L; Cellini N
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1454-60. PubMed ID: 15275732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results.
    Puthawala A; Nisar Syed AM; Gamie S; Chen YJ; Londrc A; Nixon V
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):354-62. PubMed ID: 11567809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cellular uptake, tumor retention, radiation response, and tumor pathophysiology in experimental solid tumors after an intratumoral infusion of colloidal 32P.
    Lee I; Wallner PE
    Cancer; 1997 Dec; 80(12 Suppl):2611-7. PubMed ID: 9406715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.